Lataa...
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990–2013
BACKGROUND: 23-Valent pneumococcal polysaccharide vaccine, trade name Pneumovax(®)23 (PPSV23), has been used for decades in the Unites States and has an extensive clinical record. However, limited post-licensure safety assessment has been conducted. OBJECTIVE: To analyze reports submitted to the Vac...
Tallennettuna:
| Julkaisussa: | Vaccine |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546117/ https://ncbi.nlm.nih.gov/pubmed/27087150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.04.021 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|